Journey Medical Corp (DERM)
3.55
-0.02
(-0.56%)
USD |
NASDAQ |
May 09, 13:16
Journey Medical Debt to Equity Ratio: 0.7185 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.7185 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 1988.40 |
| March 31, 2023 | 3.049 |
| December 31, 2022 | 1.341 |
| September 30, 2022 | 0.7566 |
| June 30, 2022 | 0.4251 |
| Date | Value |
|---|---|
| March 31, 2022 | 0.3566 |
| December 31, 2021 | 0.0193 |
| September 30, 2021 | -1.279 |
| June 30, 2021 | -6.622 |
| March 31, 2021 | |
| December 31, 2020 | 0.5072 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-6.622
Minimum
Jun 2021
1988.40
Maximum
Jun 2023
165.64
Average
0.4661
Median
Debt to Equity Ratio Benchmarks
| Fortress Biotech Inc | 2.832 |
| Puma Biotechnology Inc | 1.962 |
| GT Biopharma Inc | -- |
| FibroGen Inc | -0.3523 |
| Outlook Therapeutics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 76.85M |
| Total Liabilities (Quarterly) | 56.50M |
| Shareholders Equity (Quarterly) | 20.35M |
| Current Ratio | 1.348 |
| Net Debt Paydown Yield | 0.93% |